Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | HMGCR | P04035 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | FAAH | O00519 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7757111 | 0.79 | — | — | |
| SCHEMBL17803442 | 0.78 | — | — | |
| SCHEMBL24410838 | 0.74 | TSHR (0.38) | TSHRALDH1A1TP53HMGCRCHRM1 | |
| SCHEMBL9183182 | 0.74 | TSHR (0.38) | TSHRALDH1A1TP53HMGCRCHRM1 | |
| SCHEMBL11297795 | 0.73 | ALDH1A1 (0.41) | TSHRALDH1A1TP53FAAH | |
| SCHEMBL28671390 | 0.72 | TSHR (0.35) | TSHRALDH1A1TP53 | |
| SCHEMBL1002901 | 0.72 | TSHR (0.41) | TSHRALDH1A1TP53HMGCRCHRM1 | |
| SCHEMBL25246442 | 0.72 | TSHR (0.41) | TSHRALDH1A1TP53HMGCRCHRM1 | |
| SCHEMBL9340905 | 0.72 | CES2 (0.48) | TSHRALDH1A1FAAH | |
| SCHEMBL665258 | 0.71 | TSHR (0.45) | TSHRALDH1A1TP53HMGCRCHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6037361-A | GELATINASE, STROMELYSIN, COLLAGENASE, AND MATRILYSIN INHIBITORS; MULTIPLE SCLEROSIS TREATMENT; BRAIN AND NERVOUS SYSTEM DISORDERS | WARNER-LAMBERT COMPANY (US) | 2000-03-14 | — | — | US | disclosed |